Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for REPAGLINIDE

Ingredient

REPAGLINIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
REPAGLINIDE	1MG	TABLET	Resolved	2020-01-07	2020-01-18	102499
REPAGLINIDE	1MG	TABLET	Resolved	2018-11-12	2019-01-31	66646
REPAGLINIDE	0.5MG	TABLET	Resolved	2024-10-04	2024-10-21	239378
REPAGLINIDE	0.5MG	TABLET	Resolved	2018-07-11	2019-01-12	55397
REPAGLINIDE	0.5MG	TABLET	Resolved	2018-01-05	2019-01-12	35070
SANDOZ REPAGLINIDE	1MG	TABLET	Resolved	2018-10-09	2019-02-04	63497
SANDOZ REPAGLINIDE	0.5MG	TABLET	Resolved	2017-05-15	2017-06-26	10310
SANDOZ REPAGLINIDE	0.5MG	TABLET	Resolved	2018-02-05	2018-04-13	38766
SANDOZ REPAGLINIDE	0.5MG	TABLET	Resolved	2018-05-07	2018-07-14	48797
SANDOZ REPAGLINIDE	0.5MG	TABLET	Resolved	2018-11-06	2019-01-16	66331

Previous
1
2
3
4
5
Next

Showing 31 to 40 of 48

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-REPAGLINIDE			Discontinued	2018-09-08	2018-09-15	60735
APO-REPAGLINIDE			Discontinued	2018-09-08	2018-09-15	60738
APO-REPAGLINIDE			Discontinued	2018-09-08	2018-09-15	60741
GLUCONORM 0.5MG	0.5MG	TABLET	Discontinued	2023-08-09	2024-03-04	201483
GLUCONORM 1.0MG	1.0MG	TABLET	Discontinued	2023-08-09	2024-03-04	201486
GLUCONORM 2.0MG	2.0MG	TABLET	Discontinued	2023-08-09	2024-09-05	201489

1

Showing 1 to 6 of 6